Terms: = Testicular cancer AND APC, DP2, 324, ENSG00000134982, P25054, FPC, GS, DP3, DP2_5
70 results:
1. Increasing Annual cancer Incidence in Patients Age 20-49 Years: A Real-Data Study.
Ribelles N; Pascual J; Galvez-Carvajal L; Ruiz-Medina S; Garcia-Corbacho J; Benitez JC; Dominguez-Recio ME; Torres E; Oliva L; Zalabardo M; Rueda A; Alba E
JCO Glob Oncol; 2024 Mar; 10():e2300363. PubMed ID: 38513186
[TBL] [Abstract] [Full Text] [Related]
2. APOBEC3C is a novel target for the immune treatment of lower-grade gliomas.
Zhao S; Li Y; Xu J; Shen L
Neurol Res; 2024 Mar; 46(3):227-242. PubMed ID: 38007705
[TBL] [Abstract] [Full Text] [Related]
3. testicular cancer mortality in Latin America and the Caribbean: trend analysis from 1997 to 2019.
Crispin-Rios Y; Faura-Gonzales M; Torres-Roman JS; Quispe-Vicuña C; Franco-Jimenez US; Valcarcel B; Stang A; McGlynn KA
BMC Cancer; 2023 Oct; 23(1):1038. PubMed ID: 37884890
[TBL] [Abstract] [Full Text] [Related]
4. Prognostic Differences Between Surveillance and Active Treatment After Initial Orchiectomy in Patients With Stage I Mixed Germ Cell Tumors of the Testis: A Propensity Score Matching Analysis.
Du Y; Liu L; Zou B; Chen Z; Chen Q; Deng R; Yang P
J Surg Res; 2024 Feb; 294():26-36. PubMed ID: 37857140
[TBL] [Abstract] [Full Text] [Related]
5. Germline apc Alterations May Predispose to testicular Sex Cord-Stromal Tumors.
Siegmund S; Ricci C; Kao CS; Sangoi AR; Mohanty S; Fletcher CDM; Colecchia M; Acosta AM
Am J Surg Pathol; 2023 Dec; 47(12):1432-1437. PubMed ID: 37811860
[TBL] [Abstract] [Full Text] [Related]
6. Molecular Correlates of Aggressive Behavior and Biological Progression in testicular Sertoli Cell Tumors.
Rizzo NM; Sholl LM; Kao CS; Cornejo KM; Sangoi AR; Hirsch MS; Collins K; Gordetsky JB; Reyes Curcio FA; Fletcher CDM; Ulbright TM; Acosta AM
Mod Pathol; 2023 Jul; 36(7):100152. PubMed ID: 36906070
[TBL] [Abstract] [Full Text] [Related]
7. Clinicopathologic and molecular spectrum of testicular sex cord-stromal tumors not amenable to specific histopathologic subclassification.
Siegmund SE; Sholl LM; Tsai HK; Yang Y; Vasudevaraja V; Tran I; Snuderl M; Fletcher CDM; Cornejo KM; Idrees MT; Al-Obaidy KI; Collins K; Gordetsky JB; Wobker SE; Hirsch MS; Trpkov K; Yilmaz A; Anderson WJ; Quiroga-Garza G; Magi-Galluzzi C; Canete-Portillo S; Acosta AM
Mod Pathol; 2022 Dec; 35(12):1944-1954. PubMed ID: 36180576
[TBL] [Abstract] [Full Text] [Related]
8. Comparative molecular analysis of testicular Leydig cell tumors demonstrates distinct subsets of neoplasms with aggressive histopathologic features.
Rizzo NM; Sholl LM; Idrees MT; Cheville JC; Gupta S; Cornejo KM; Miyamoto H; Hirsch MS; Collins K; Acosta AM
Mod Pathol; 2021 Oct; 34(10):1935-1946. PubMed ID: 34103665
[TBL] [Abstract] [Full Text] [Related]
9. Trends in cancer Incidence in US Adolescents and Young Adults, 1973-2015.
Scott AR; Stoltzfus KC; Tchelebi LT; Trifiletti DM; Lehrer EJ; Rao P; Bleyer A; Zaorsky NG
JAMA Netw Open; 2020 Dec; 3(12):e2027738. PubMed ID: 33258907
[TBL] [Abstract] [Full Text] [Related]
10. Increasing Incidence of testicular Germ Cell Tumors among Racial/Ethnic Minorities in the United States.
Ghazarian AA; McGlynn KA
Cancer Epidemiol Biomarkers Prev; 2020 Jun; 29(6):1237-1245. PubMed ID: 32385118
[TBL] [Abstract] [Full Text] [Related]
11. Bladder, penile, renal pelvis and testis cancers: A population based analysis of incidence and survival 1977-2013.
Tempo J; Logan C; O'Callaghan M; Kahokehr A; Kichenadasse G; D'Onise K; Foreman D
Cancer Epidemiol; 2020 Apr; 65():101692. PubMed ID: 32151978
[TBL] [Abstract] [Full Text] [Related]
12. Changing Trends in the Referral and Timing of Treatment for Congenital Cryptorchidism: A Single-Center Experience from Bosnia and Herzegovina.
Zvizdic Z; Islamovic B; Milisic E; Jonuzi A; Vranic S
J Pediatr Surg; 2020 Sep; 55(9):1965-1968. PubMed ID: 31500876
[TBL] [Abstract] [Full Text] [Related]
13. A Population-Based Analysis of Incidence, Mortality, and Survival in testicular cancer Patients in Lithuania.
Drevinskaite M; Patasius A; Kincius M; Jievaltas M; Smailyte G
Medicina (Kaunas); 2019 Aug; 55(9):. PubMed ID: 31480363
[No Abstract] [Full Text] [Related]
14. testicular cancer in Geneva, Switzerland, 1970-2012: incidence trends, survival and risk of second cancer.
Schaffar R; Pant S; Bouchardy C; Schubert H; Rapiti E
BMC Urol; 2019 Jul; 19(1):64. PubMed ID: 31291913
[TBL] [Abstract] [Full Text] [Related]
15. testicular cancer mortality in Brazil: trends and predictions until 2030.
Soares SCM; Dos Santos KMR; de Morais Fernandes FCG; Barbosa IR; de Souza DLB
BMC Urol; 2019 Jul; 19(1):59. PubMed ID: 31277621
[TBL] [Abstract] [Full Text] [Related]
16. "Hey, that could be me": The role of similarity in narrative persuasion.
Ooms J; Hoeks J; Jansen C
PLoS One; 2019; 14(4):e0215359. PubMed ID: 30998694
[TBL] [Abstract] [Full Text] [Related]
17. Risk of Gynecomastia with Users of Proton Pump Inhibitors.
He B; Carleton B; Etminan M
Pharmacotherapy; 2019 May; 39(5):614-618. PubMed ID: 30865318
[TBL] [Abstract] [Full Text] [Related]
18. Incorporating non-biological factors into the TNM staging system for better prognostication and decision-making in testicular cancer.
Huang Y; Sheng H; Zhang J; Liu Q; Ye D; Shi G
World J Urol; 2019 Oct; 37(10):2165-2173. PubMed ID: 30554272
[TBL] [Abstract] [Full Text] [Related]
19. Delivery of chemotherapy for testicular cancer in routine practice: A population-based study.
Karim S; Wei X; Leveridge MJ; Siemens DR; Robinson AG; Bedard PL; Booth CM
Urol Oncol; 2019 Mar; 37(3):183.e17-183.e24. PubMed ID: 30478011
[TBL] [Abstract] [Full Text] [Related]
20. Trends in rates of inpatients treated for testicular cancer in France, 2000-2014.
Kudjawu YC; de Maria F; Beltzer N
Andrology; 2018 Sep; 6(5):798-804. PubMed ID: 29952145
[TBL] [Abstract] [Full Text] [Related]
[Next]
